COMMUNIQUÉS West-GlobeNewswire

Zafgen to Present at Deutsche Bank 43rd Annual Health Care Conference
02/05/2018
BOSTON, May 02, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq: ZFGN ), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]
Clearside Biomedical to Report First Quarter 2018 Financial Results on May 9, 2018 – Conference Call to Follow
02/05/2018
ALPHARETTA, Ga., May 02, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, [...]
Dova Pharmaceuticals to Announce First Quarter 2018 Financial Results on May 9, 2018
02/05/2018
DURHAM, N.C., May 02, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) will host a conference call on Wednesday, May 9, 2018 at 4:30 p.m. ET to discuss first quarter 2018 financial results and recent [...]
Globus Medical Reports First Quarter 2018 Results
02/05/2018
AUDUBON, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2018. Worldwide [...]
Dynavax to Host First Quarter 2018 Financial Results Conference Call
02/05/2018
BERKELEY, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) today announced that it will report financial results for the first quarter ended March 31, 2018 after market close on [...]
The Ensign Group Reports First Quarter Results
02/05/2018
Conference Call and Webcast scheduled for tomorrow, May 3, 2018 at 10:00 am PT MISSION VIEJO, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG ), the parent company of the Ensign™ group of [...]
Humanigen Announces Preclinical Findings Presented on Lenzilumab’s Potential to Optimize CAR-T Therapy
02/05/2018
Lenzilumab effectively neutralizes GM-CSF CAR-T cells maintained robust anti-tumor activity in combination with lenzilumab GM-CSF depletion by lenzilumab may increase CAR-T expansion BRISBANE, Calif., May 02, 2018 ( [...]
Sandoz receives complete response letter from the US FDA for proposed biosimilar rituximab
02/05/2018
Holzkirchen, May 2, 2018 - Sandoz, a Novartis division, announced today that the US Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the Biologics Licensing Application (BLA) for [...]
TRACON to Report First Quarter 2018 Company Highlights and Financial Results on May 9, 2018
02/05/2018
SAN DIEGO, May 02, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]
miRagen Therapeutics Presents New Preclinical Data Supporting use of MicroRNA-Targeted Therapies for Ophthalmic Diseases
02/05/2018
Dosing with microRNA mimics of the microRNA-183/96/182 cluster led to functional improvement of photoreceptors and vision in retinal degeneration model MRG-201 dosing inhibited the expression of multiple factors [...]
Conformis Reports First Quarter 2018 Financial Results
02/05/2018
BILLERICA, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS ), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint [...]
Ovid Therapeutics to Present at Deutsche Bank’s 43rd Annual Health Care Conference on May 9, 2018
02/05/2018
NEW YORK, May 02, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID ), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological disorders, today [...]
Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 9, 2018
02/05/2018
GAITHERSBURG, Md., May 02, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX ) today announced it will report its first quarter 2018 financial and operating results following the close of U.S. financial markets on [...]
Recro Pharma Announces Commercial Team Additions
02/05/2018
MALVERN, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]
Conatus Pharmaceuticals Reports First Quarter 2018 Financial Results and Program Updates
02/05/2018
SAN DIEGO, May 02, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq: CNAT ), a biotechnology company focused on the development of novel medicines to treat liver disease, today announced financial results [...]
GenMark Diagnostics to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
02/05/2018
CARLSBAD, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK ) a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that President and Chief [...]
Pacific Biosciences of California, Inc. Announces First Quarter 2018 Financial Results
02/05/2018
MENLO PARK, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB ) today announced financial results for its first quarter ended March 31, 2018. Total revenue for the first [...]
Immune Design Reports First Quarter 2018 Financial Results and Provides Corporate Update
02/05/2018
The higher dose of CMB305 was deemed safe and cleared for the pivotal Phase 3 The 20ug dose of G100 shows a two-fold increase in TILs, higher than that seen at the 10ug dose Conference call at 1:30 pm Pacific today [...]
Collegium to Present at the Deutsche Bank Health Care Conference
02/05/2018
CANTON, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL ) today announced that management will present at the Deutsche Bank 43 rd Annual Health Care Conference on Tuesday, May 8, [...]

Pages